CATHAY BIOTECH INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 52.68 CNY | -1.35% |
|
-3.85% | -4.18% |
| 04-29 | Cathay Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 04-15 | Cathay Biotech's Q1 Profit to Surge Up to 100%, Revenue to Climb 43%; Shares Up 6% | MT |
ETFs positioned on Cathay Biotech Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.69% | 1 M€ | -10.43% | - | |
| 0.81% | 45 M€ | -12.12% | - | |
| 0.81% | 45 M€ | -12.06% | - | |
| 0.81% | 38 M€ | -10.61% | - | |
| 0.00% | 34 M€ | +3.53% | - |
Cathay Biotech Inc is a China-based company engaged in research, development, production and sales of biobased materials. The Company's primary products are biological long-chain dibasic acids and bio-based polyamide series, including lauric acid and brazilian acid, which are used in long-chain polyamides, fragrances, hot melt adhesives, lubricants, powder coatings and other areas. The Company sells its products to domestic and overseas markets.
Sector
Specialty Chemicals
Calendar
07/08/2024
- Q2 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -4.18% | 4.23B | |
| +14.04% | 28.33B | |
| +14.12% | 1.78B | |
| -9.28% | 649M | |
| -15.04% | 443M | |
| -15.76% | 108M | |
| -11.41% | 53.16M |
- Stock Market
- Equities
- 688065 Stock
- Funds and ETFs Cathay Biotech Inc.
